loadpatents
name:-0.1392719745636
name:-0.078894138336182
name:-0.24308395385742
Hinkle; Gregory Patent Filings

Hinkle; Gregory

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hinkle; Gregory.The latest application filed is for "serum amyloid p component (apcs) irna compositions and methods of use thereof".

Company Profile
55.86.137
  • Hinkle; Gregory - Plymouth MA
  • Hinkle; Gregory - Cambridge MA
  • Hinkle; Gregory - Plymoutth MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220305045 - Fitzgerald; Kevin ;   et al.
2022-09-29
Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof
Grant 11,434,487 - Fitzgerald , et al. September 6, 2
2022-09-06
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Grant 11,419,942 - Foster , et al. August 23, 2
2022-08-23
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
Grant 11,408,001 - Fitzgerald , et al. August 9, 2
2022-08-09
Lipid Formulated Compositions And Methods For Inhibiting Expression Of Serum Amyloid A Gene
App 20220243199 - de Fougerolles; Antonin ;   et al.
2022-08-04
Compositions And Methods For Inhibiting Expression Of The Lect2 Gene
App 20220213473 - Bettencourt; Brian ;   et al.
2022-07-07
Polynucleotide Agents Targeting Complement Component C5 And Methods Of Use Thereof
App 20220162602 - Hinkle; Gregory
2022-05-26
Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof
Grant 11,319,539 - Fitzgerald , et al. May 3, 2
2022-05-03
KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220127618 - Fitzgerald; Kevin ;   et al.
2022-04-28
PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220117999 - Fitzgerald; Kevin ;   et al.
2022-04-21
Angiopoietin-like 3 (angptl3) Irna Compositions And Methods Of Use Thereof
App 20220119815 - Querbes; William ;   et al.
2022-04-21
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220042012 - Butler; James ;   et al.
2022-02-10
Polynucleotide Agents Targeting Programmed Cell Death 1 Ligand 1 (pd-l1) And Methods Of Use Thereof
App 20220033825 - Hinkle; Gregory
2022-02-03
Serum amyloid P component (APCS) iRNA compositions and methods of use thereof
Grant 11,229,663 - Fitzgerald , et al. January 25, 2
2022-01-25
Polynucleotide Agents Targeting Aminolevulinic Acid Synthase-1 (alas1) And Uses Thereof
App 20220002734 - Hinkle; Gregory
2022-01-06
Polynucleotide Agents Targeting Hydroxyacid Oxidase (glycolate Oxidase, Hao1) And Methods Of Use Thereof
App 20210402007 - Hinkle; Gregory
2021-12-30
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 11,198,872 - Querbes , et al. December 14, 2
2021-12-14
17 -Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof
App 20210380985 - Hinkle; Gregory ;   et al.
2021-12-09
17.beta.-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof
Grant 11,180,757 - Hinkle , et al. November 23, 2
2021-11-23
Compositions And Methods For Inhibiting Expression Of The Lect2 Gene
App 20210348162 - Hinkle; Gregory ;   et al.
2021-11-11
KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210332367 - Hinkle; Gregory
2021-10-28
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
Grant 11,149,273 - de Fougerolles , et al. October 19, 2
2021-10-19
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210317452 - Sehgal; Alfica ;   et al.
2021-10-14
Polynucleotide Agents Targeting Patatin-like Phospholipase Domain Containing 3 (pnpla3) And Methods Of Use Thereof
App 20210317458 - Hinkle; Gregory
2021-10-14
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
Grant 11,142,766 - Fitzgerald , et al. October 12, 2
2021-10-12
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210310006 - Foster; Donald ;   et al.
2021-10-07
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
Grant 11,136,582 - Fitzgerald , et al. October 5, 2
2021-10-05
Complement Component C3 Irna Compositions And Methods Of Use Thereof
App 20210261959 - Hinkle; Gregory ;   et al.
2021-08-26
Organic compositions to treat HSF1-related diseases
Grant 11,091,761 - Hinkle , et al. August 17, 2
2021-08-17
Factor XII (Hageman Factor) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), and Kininogen 1 (KNG1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210246447 - Akinc; Akin ;   et al.
2021-08-12
LACTATE DEHYDROGENASE A (LDHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210228614 - Erbe; David ;   et al.
2021-07-29
Polynucleotide Agents Targeting Factor Xii (hageman Factor) (f12) And Methods Of Use Thereof
App 20210222176 - Hinkle; Gregory
2021-07-22
Insulin-like growth factor binding protein, acid labile subunit (IGFALS) and insulin-like growth factor 1 (IGF-1) iRNA compositions and methods of use thereof
Grant 11,066,670 - Butler , et al. July 20, 2
2021-07-20
Hepatitis B virus (HBV) iRNA compositions and methods of use thereof
Grant 11,060,091 - Hinkle , et al. July 13, 2
2021-07-13
Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
Grant 11,052,103 - Fitzgerald , et al. July 6, 2
2021-07-06
PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210189391 - Hinkle; Gregory
2021-06-24
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
Grant 11,034,958 - Fitzgerald , et al. June 15, 2
2021-06-15
GLUCOKINASE (GCK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210171956 - Fitzgerald; Kevin ;   et al.
2021-06-10
Polynucleotide Agents Targeting Angiotensinogen (agt) And Methods Of Use Thereof
App 20210169915 - Hinkle; Gregory
2021-06-10
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Grant 11,015,201 - Foster , et al. May 25, 2
2021-05-25
Polynucleotide Agents Targeting Serpinc1 (at3) And Methods Of Use Thereof
App 20210123049 - Hinkle; Gregory
2021-04-29
Polynucleotide agents targeting programmed cell death 1 ligand 1 (PD-L1) and methods of use thereof
Grant 10,982,215 - Hinkle April 20, 2
2021-04-20
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210108203 - Fitzgerald; Kevin ;   et al.
2021-04-15
Polynucleotide agents targeting aminolevulinic acid synthase-1 (ALAS1) and uses thereof
Grant 10,968,452 - Hinkle April 6, 2
2021-04-06
Compositions And Methods For Inhibiting Expression Of The Lect2 Gene
App 20210095289 - Hinkle; Gregory
2021-04-01
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210095290 - Foster; Donald ;   et al.
2021-04-01
Compositions And Methods Directed To Treating Liver Fibrosis
App 20210087218 - Hinkle; Gregory ;   et al.
2021-03-25
GNAQ targeted dsRNA compositions and methods for inhibiting expression
Grant 10,954,516 - Gollob , et al. March 23, 2
2021-03-23
Polynucleotide agents targeting hydroxyacid oxidase (glycolate oxidase, HAO1) and methods of use thereof
Grant 10,946,107 - Hinkle March 16, 2
2021-03-16
Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof
Grant 10,934,544 - Akinc , et al. March 2, 2
2021-03-02
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210046187 - Foster; Donald ;   et al.
2021-02-18
Serpina1 iRNA compositions and methods of use thereof
Grant 10,920,223 - Sehgal , et al. February 16, 2
2021-02-16
Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof
Grant 10,889,813 - Hinkle January 12, 2
2021-01-12
STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210002638 - Fitzgerald; Kevin ;   et al.
2021-01-07
Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof
Grant 10,883,107 - Hinkle January 5, 2
2021-01-05
Polynucleotide Agents Targeting Angiotensinogen (agt) And Methods Of Use Thereof
App 20200384011 - Hinkle; Gregory
2020-12-10
Kisspeptin 1 (kiss1) Irna Compositions And Methods Of Use Thereof
App 20200385719 - Soundarapandian; Mangala Meenakshi ;   et al.
2020-12-10
Glucokinase (GCK) iRNA compositions and methods of use thereof
Grant 10,844,384 - Fitzgerald , et al. November 24, 2
2020-11-24
SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200345758 - Fitzgerald; Kevin ;   et al.
2020-11-05
Assays And Methods For Determining Expression Of The Lect2 Gene
App 20200339987 - Hinkle; Gregory ;   et al.
2020-10-29
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Grant 10,814,007 - Foster , et al. October 27, 2
2020-10-27
High Mobility Group Box-1 (hmgb1) Irna Compositions And Methods Of Use Thereof
App 20200308588 - Hinkle; Gregory ;   et al.
2020-10-01
Xanthine Dehydrogenase (xdh) Irna Compositions And Methods Of Use Thereof
App 20200299698 - Fitzgerald; Kevin ;   et al.
2020-09-24
HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200291405 - Hinkle; Gregory ;   et al.
2020-09-17
Compositions and Methods for Inhibiting Expression of Transthyretin
App 20200283766 - Sah; Dinah Wen-Yee ;   et al.
2020-09-10
Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof
Grant 10,767,177 - Fitzgerald , et al. Sep
2020-09-08
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITI
App 20200277599 - Butler; James ;   et al.
2020-09-03
Compositions and methods for inhibiting expression of the LECT2 gene
Grant 10,745,702 - Hinkle A
2020-08-18
Polynucleotide Agents Targeting Patatin-like Phospholipase Domain Containing 3 (pnpla3) And Methods Of Use Thereof
App 20200248188 - Kind Code
2020-08-06
Lipid Formulated Compositions And Methods For Inhibiting Expression Of Serum Amyloid A Gene
App 20200239887 - de Fougerolles; Antonin ;   et al.
2020-07-30
Angiopoietin-like 3 (angptl3) Irna Compositions And Methods Of Use Thereof
App 20200224201 - Querbes; William ;   et al.
2020-07-16
Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof
Grant 10,709,728 - Hinkle
2020-07-14
LACTATE DEHYDROGENASE A (LDHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200206258 - Erbe; David ;   et al.
2020-07-02
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200199591 - Fitzgerald; Kevin ;   et al.
2020-06-25
Serpina1 iRNA compositions and methods of use thereof
Grant 10,683,504 - Sehgal , et al.
2020-06-16
KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200172909 - Fitzgerald; Kevin ;   et al.
2020-06-04
Compositions and methods directed to treating liver fibrosis
Grant 10,669,303 - Hinkle , et al.
2020-06-02
HEPATITIS B VIRUS (HBV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200140864 - Hinkle; Gregory ;   et al.
2020-05-07
Hepatitis D virus (HDV) iRNA compositions and methods of use thereof
Grant 10,640,770 - Hinkle , et al.
2020-05-05
FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) iRNA COMPOSITIONS AN
App 20200131513 - Akinc; Akin ;   et al.
2020-04-30
LACTATE DEHYDROGENASE A (LDHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200113927 - Erbe; David ;   et al.
2020-04-16
Polynucleotide Agents Targeting Serpinc1 (at3) And Methods Of Use Thereof
App 20200102560 - Hinkle; Gregory
2020-04-02
Polynucleotide Agents Targeting Complement Component C5 And Methods Of Use Thereof
App 20200095578 - Hinkle; Gregory
2020-03-26
Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (PNPLA3) and methods of use thereof
Grant 10,597,661 - Hinkle
2020-03-24
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200080085 - Sehgal; Alfica ;   et al.
2020-03-12
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200080088 - Fitzgerald; Kevin ;   et al.
2020-03-12
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 10,570,393 - Querbes , et al. Feb
2020-02-25
Organic compositions to treat beta-ENaC-related diseases
Grant 10,550,391 - De Fougerolles , et al. Fe
2020-02-04
Hepatitis B virus (HBV) iRNA compositions and methods of use thereof
Grant 10,513,703 - Hinkle , et al. Dec
2019-12-24
Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof
Grant 10,494,632 - Butler , et al. De
2019-12-03
Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
Grant 10,472,628 - de Fougerolles , et al. Nov
2019-11-12
Compositions and Methods for Inhibiting Expression of Transthyretin
App 20190309293 - Sah; Dinah Wen-Yee ;   et al.
2019-10-10
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20190298842 - Foster; Donald ;   et al.
2019-10-03
Organic Compositions To Treat Hsf1-related Diseases
App 20190276827 - Hinkle; Gregory ;   et al.
2019-09-12
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
Grant 10,407,679 - Fitzgerald , et al. Sept
2019-09-10
Polynucleotide agents targeting complement component C5 and methods of use thereof
Grant 10,400,238 - Hinkle Sep
2019-09-03
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
Grant 10,370,666 - Fitzgerald , et al.
2019-08-06
PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20190216845 - Fitzgerald; Kevin ;   et al.
2019-07-18
Polynucleotide agents targeting Serpinc1 (AT3) and methods of use thereof
Grant 10,344,278 - Hinkle July 9, 2
2019-07-09
Organic compositions to treat HSF1-related diseases
Grant 10,287,582 - Hinkle , et al.
2019-05-14
Compositions And Methods For Inhibiting Expression Of The Lect2 Gene
App 20190119674 - Bettencourt; Brian ;   et al.
2019-04-25
GNAQ Targeted dsRNA Compositions and Methods for Inhibiting Expression
App 20190106694 - Gollob; Jared ;   et al.
2019-04-11
Compositions and methods for inhibiting expression of transthyretin
Grant 10,240,152 - Sah , et al.
2019-03-26
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Grant 10,238,749 - Foster , et al.
2019-03-26
Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
Grant 10,231,988 - Fitzgerald , et al.
2019-03-19
Polynucleotide Agents Targeting Factor Xii (hageman Factor) (f12) And Methods Of Use Thereof
App 20190024088 - Hinkle; Gregory
2019-01-24
Polynucleotide Agents Targeting Programmed Cell Death 1 Ligand 1 (pd-l1) And Methods Of Use Thereof
App 20180371465 - Hinkle; Gregory
2018-12-27
Organic Compositions to Treat Beta-ENaC-Related Diseases
App 20180355362 - De Fougerolles; Antonin ;   et al.
2018-12-13
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20180346910 - Sehgal; Alfica ;   et al.
2018-12-06
Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
App 20180282725 - de Fougerolles; Antonin ;   et al.
2018-10-04
PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20180273947 - Hinkle; Gregory
2018-09-27
STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20180273955 - Fitzgerald; Kevin ;   et al.
2018-09-27
Organic compositions to treat Beta-ENaC-related diseases
Grant 10,081,811 - De Fougerolles , et al. September 25, 2
2018-09-25
Compositions and methods for inhibiting expression of the LECT2 gene
Grant 10,077,444 - Fitzgerald , et al. September 18, 2
2018-09-18
Xanthine Dehydrogenase (xdh) Irna Compositions And Methods Of Use Thereof
App 20180216114 - Fitzgerald; Kevin ;   et al.
2018-08-02
Serpina1 iRNA compositions and methods of use thereof
Grant 10,030,244 - Sehgal , et al. July 24, 2
2018-07-24
Polynucleotide Agents Targeting Patatin-like Phospholipase Domain Containing 3 (pnpla3) And Methods Of Use Thereof
App 20180201936 - Hinkle; Gregory
2018-07-19
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20180201929 - Butler; James ;   et al.
2018-07-19
GLUCOKINASE (GCK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20180195073 - Fitzgerald; Kevin ;   et al.
2018-07-12
Polynucleotide Agents Targeting Angiotensinogen (agt) And Methods Of Use Thereof
App 20180169129 - Hinkle; Gregory
2018-06-21
Compositions And Methods For Inhibiting Expression Of The Lect2 Gene
App 20180135057 - Hinkle; Gregory
2018-05-17
GNAQ targeted dsRNA compositions and methods for inhibiting expression
Grant 9,963,700 - Gollob , et al. May 8, 2
2018-05-08
Factor XII (Hageman Factor) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), and Kininogen 1 (KNG1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20180100150 - Akinc; Akin ;   et al.
2018-04-12
Polynucleotide Agents Targeting Hydroxyacid Oxidase (glycolate Oxidase, Hao1) And Methods Of Use Thereof
App 20180092990 - Hinkle; Gregory
2018-04-05
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20180087054 - Querbes; William ;   et al.
2018-03-29
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
Grant 9,868,950 - de Fougerolles , et al. January 16, 2
2018-01-16
HEPATITIS B VIRUS (HBV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20170349900 - Hinkle; Gregory ;   et al.
2017-12-07
HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20170349901 - Hinkle; Gregory ;   et al.
2017-12-07
PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20170340661 - Fitzgerald; Kevin ;   et al.
2017-11-30
Organic Compositions to Treat Beta-ENaC-Related Diseases
App 20170327829 - De Fougerolles; Antonin ;   et al.
2017-11-16
Compositions and Methods for Inhibiting Expression of Transthyretin
App 20170321213 - Sah; Dinah Wen-Yee ;   et al.
2017-11-09
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20170260527 - Fitzgerald; Kevin ;   et al.
2017-09-14
Organic compositions to treat beta-ENaC-related diseases
Grant 9,752,152 - De Fougerolles , et al. September 5, 2
2017-09-05
Polynucleotide Agents Targeting Serpinc1 (at3) And Methods Of Use Thereof
App 20170240892 - Hinkle; Gregory
2017-08-24
GNAQ TARGETED dsRNA COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION
App 20170240890 - Gollob; Jared ;   et al.
2017-08-24
Polynucleotide Agents Targeting Aminolevulinic Acid Synthase-1 (alas1) And Uses Thereof
App 20170204418 - Hinkle; Gregory
2017-07-20
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20170189541 - Foster; Donald ;   et al.
2017-07-06
Polynucleotide Agents Targeting Complement Component C5 And Methods Of Use Thereof
App 20170183659 - Hinkle; Gregory
2017-06-29
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20170114342 - Sehgal; Alfica ;   et al.
2017-04-27
Organic Compositions To Treat Hsf1-related Diseases
App 20170073678 - Hinkle; Gregory ;   et al.
2017-03-16
Serapina1 iRNA compositions and methods of use thereof
Grant 9,574,192 - Sehgal , et al. February 21, 2
2017-02-21
GNAQ targeted dsRNA compositions and methods for inhibiting expression
Grant 9,566,295 - Gollob , et al. February 14, 2
2017-02-14
Organic compositions to treat HSF1-related diseases
Grant 9,540,643 - Hinkle , et al. January 10, 2
2017-01-10
Lipid Formulated Dsrna Targeting The Pcsk9 Gene
App 20170000815 - Fitzgerald; Kevin ;   et al.
2017-01-05
Compositions and Methods for Inhibition of PCSK9 Genes
App 20160354404 - Hinkle; Gregory ;   et al.
2016-12-08
KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20160340679 - Fitzgerald; Kevin ;   et al.
2016-11-24
Organic Compositions to Treat Beta-ENaC-Related Diseases
App 20160272979 - De Fougerolles; Antonin ;   et al.
2016-09-22
Compositions and Methods for Inhibiting Expression of Transthyretin
App 20160264963 - Sah; Dinah Wen-Yee ;   et al.
2016-09-15
Compositions And Methods For Inhibiting Expression Of The Lect2 Gene
App 20160264966 - Fitzgerald; Kevin ;   et al.
2016-09-15
Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
App 20160194633 - de Fougerolles; Antonin ;   et al.
2016-07-07
Organic compositions to treat beta-ENaC-related diseases
Grant 9,376,683 - De Fougerolles , et al. June 28, 2
2016-06-28
Compositions And Methods For Inhibiting Expression Of GSK-3 Genes
App 20160024497 - Sah; Dinah Wen-Yee ;   et al.
2016-01-28
Compositions and methods for inhibiting expression of transthyretin
Grant 9,234,196 - Sah , et al. January 12, 2
2016-01-12
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
Grant 9,206,421 - de Fougerolles , et al. December 8, 2
2015-12-08
Organic Compositions To Treat Hsf1-related Diseases
App 20150284721 - HINKLE; Gregory ;   et al.
2015-10-08
Organic Compositions to Treat Beta-ENaC-Related diseases
App 20150275218 - DE FOUGEROLLES; Antonin ;   et al.
2015-10-01
Organic compositions to treat HSF1-related diseases
Grant 9,096,637 - Hinkle , et al. August 4, 2
2015-08-04
Organic compositions to treat Beta-ENaC-related diseases
Grant 9,080,175 - De Fougerolles , et al. July 14, 2
2015-07-14
Compositions and methods for inhibiting expression of GSK-3 genes
Grant 9,029,525 - Sah , et al. May 12, 2
2015-05-12
GNAQ TARGETED dsRNA COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION
App 20150099794 - Gollob; Jared ;   et al.
2015-04-09
Compositions and Methods for Inhibiting Expression of XBP-1 Gene
App 20140256791 - Fitzgerald; Kevin ;   et al.
2014-09-11
Compositions And Methods For Inhibiting Expression Of Transthyretin
App 20140194493 - Sah; Dinah Wen-Yee ;   et al.
2014-07-10
Compositions and methods for inhibiting expression of XBP-1 gene
Grant 8,765,932 - Fitzgerald , et al. July 1, 2
2014-07-01
Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
App 20140179759 - de Fougerolles; Antonin ;   et al.
2014-06-26
Compositions and methods for inhibiting expression of transthyretin
Grant 8,741,866 - Sah , et al. June 3, 2
2014-06-03
Lipid Formulated Dsrna Targeting The Pcsk9 Gene
App 20140121263 - Fitzgerald; Kevin ;   et al.
2014-05-01
ORGANIC COMPOSITIONS TO TREAT Beta-ENaC-RELATED DISEASES
App 20140107179 - DE FOUGEROLLES; Antonin ;   et al.
2014-04-17
Compositions And Methods For Enhancing Production Of A Biological Product
App 20140099666 - Rossomando; Anthony ;   et al.
2014-04-10
Organic Compositions To Treat Hsf1-related Diseases
App 20140039039 - HINKLE; Gregory ;   et al.
2014-02-06
Organic compositions to treat HSF1-related diseases
Grant 8,623,838 - Chen , et al. January 7, 2
2014-01-07
Cell-based Bioprocessing
App 20140004565 - Rossomando; Anthony ;   et al.
2014-01-02
Organic compositions to treat Beta-ENaC-related diseases
Grant 8,598,335 - De Fougerolles , et al. December 3, 2
2013-12-03
Lipid formulated dsRNA targeting the PCSK9 gene
Grant 8,598,139 - Fitzgerald , et al. December 3, 2
2013-12-03
Compositions and Methods for Inhibition of PCSK9 Genes
App 20130289094 - Hinkle; Gregory ;   et al.
2013-10-31
Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
Grant 8,546,554 - de Fougerolles , et al. October 1, 2
2013-10-01
Organic compositions to treat HSF1-related diseases
Grant 8,481,509 - Hinkle , et al. July 9, 2
2013-07-09
Lipid Formulated Dsrna Targeting The Pcsk9 Gene
App 20130035371 - Fitzgerald; Kevin ;   et al.
2013-02-07
Compositions and Methods for Inhibiting Expression of XBP-1 Gene
App 20130023580 - Fitzgerald; Kevin ;   et al.
2013-01-24
Compositions And Methods For Inhibiting Expression Of GSK-3 Genes
App 20130012572 - Sah; Dinah Wen-Yee ;   et al.
2013-01-10
Organic Compositions to Treat Beta-ENaC-Related Diseases
App 20130012571 - DE FOUGEROLLES; Antonin ;   et al.
2013-01-10
Organic compositions to treat beta-ENaC-related diseases
Grant 8,344,131 - De Fougerolles , et al. January 1, 2
2013-01-01
Organic compositions to treat beta-ENaC-related diseases
Grant 8,344,127 - De Fougerolles , et al. January 1, 2
2013-01-01
Organic compositions to treat Beta-ENaC-related diseases
Grant 8,344,130 - De Fougerolles , et al. January 1, 2
2013-01-01
Compositions and methods for inhibiting expression of XBP-1 gene
Grant 8,344,126 - Fitzgerald , et al. January 1, 2
2013-01-01
Organic compositions to treat Beta-ENaC-related diseases
Grant 8,344,129 - De Fougerolles , et al. January 1, 2
2013-01-01
GNAQ targeted dsRNA compositions and methods for inhibiting expression
Grant 8,324,368 - Gollob , et al. December 4, 2
2012-12-04
Organic compositions to treat HSF1-related diseases
Grant 8,293,718 - Hinkle , et al. October 23, 2
2012-10-23
Lipid formulated dsRNA targeting the PCSK9 gene
Grant 8,273,869 - Fitzgerald , et al. September 25, 2
2012-09-25
Compositions And Methods For Inhibiting Expression Of Transthyretin
App 20120225927 - Sah; Dinah Wen-Yee ;   et al.
2012-09-06
Organic Compositions To Treat Hsf1-related Diseases
App 20120129914 - HINKLE; Gregory ;   et al.
2012-05-24
Organic Compositions To Treat Hsf1-related Diseases
App 20120129915 - HINKLE; Gregory ;   et al.
2012-05-24
Organic Compositions to Treat Beta-ENaC-Related Diseases
App 20120122960 - DE FOUGEROLLES; Antonin ;   et al.
2012-05-17
Organic Compositions to Treat Beta-ENaC-Related Diseases
App 20120115933 - DE FOUGEROLLES; Antonin ;   et al.
2012-05-10
Organic Compositions to Treat Beta-ENaC-Related Diseases
App 20120115934 - DE FOUGEROLLES; Antonin ;   et al.
2012-05-10
Compositions and methods for inhibiting expression of transthyretin
Grant 8,168,775 - Sah , et al. May 1, 2
2012-05-01
Compositions And Methods For Inhibiting Expression Of MIG-12 Gene
App 20120041051 - Fitzgerald; Kevin ;   et al.
2012-02-16
Compositions And Methods For Increasing Cellular Uptake Of RNAi Via SID-1
App 20120016006 - Hinkle; Gregory ;   et al.
2012-01-19
Organic Compositions to Treat Beta-ENaC-Related Diseases
App 20110263681 - DE FOUGEROLLES; Antonin ;   et al.
2011-10-27
Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
App 20110263684 - de Fougerolles; Antonin ;   et al.
2011-10-27
Compositions And Methods For Inhibiting Expression Of GSK-3 Genes
App 20110184046 - Sah; Dinah Wen-Yee ;   et al.
2011-07-28
Organic Compositions To Treat Hsf1-related Diseases
App 20110166058 - HINKLE; Gregory ;   et al.
2011-07-07
Compositions and Methods for Inhibiting Expression of XBP-1 Gene
App 20110152350 - Fitzgerald; Kevin ;   et al.
2011-06-23
Compositions and methods for inhibiting expression of XBP-1 gene
Grant 7,875,711 - Fitzgerald , et al. January 25, 2
2011-01-25
Lipid Formulated Dsrna Targeting The Pcsk9 Gene
App 20110015252 - Fitzgerald; Kevin ;   et al.
2011-01-20
Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
App 20100293663 - LA ROSA; Thomas ;   et al.
2010-11-18
GNAQ Targeted dsRNA Compositions And Methods For Inhibiting Expression
App 20100168206 - Gollob; Jared ;   et al.
2010-07-01
Compositions and Methods for Inhibiting Expression of Transthyretin
App 20100120893 - Sah; Dinah Wen-Yee ;   et al.
2010-05-13
Compositions and Methods for Inhibiting Expression of XBP-1 Gene
App 20090275638 - Fitzgerald; Kevin ;   et al.
2009-11-05
Method of producing short hairpin library
App 20070141594 - Luo; Biao ;   et al.
2007-06-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed